ChengRang

Viz.ai

AI Industry Paid

AI medical imaging platform for rapid diagnosis of stroke, heart disease and other emergencies

Medical ImagingEmergency DiagnosisStroke
Visit Viz.ai

Disclaimer: Review content represents our editorial team's views and experience, not commercial recommendation or investment advice. Product info and pricing may change; refer to official sources.

Overview

Viz.ai is an FDA-approved AI-driven medical imaging diagnostic and care coordination platform that focuses on real-time analysis of medical images such as CT scans using advanced algorithms to assist clinical decision-making. Its core product, Viz Neuro Suite, can automatically identify key signs of stroke such as large vessel occlusion (LVO) and accelerate the transfer and treatment process. The platform also extends to multiple specialties including cardiology, pulmonology, and oncology. With over 50 FDA-cleared algorithms, Viz.ai aims to bridge the information gap between patients, clinicians, and life-saving treatments, improving medical efficiency and patient outcomes.

Key Features

Use Cases

Pros

Pricing

Viz.ai is a paid commercial product. Specific pricing requires contacting the sales team, typically customized based on hospital size, deployed modules, and number of users.

Summary

Viz.ai is suitable for large hospitals, regional medical networks, and emergency centers, especially those needing to quickly handle time-sensitive conditions such as stroke and cardiovascular emergencies. Its core advantage lies in AI-driven real-time image analysis and automated care coordination, which can significantly shorten the window from diagnosis to treatment, improving patient survival rates and prognosis quality.

Category
AI Industry
Pricing
Paid
Tags
Medical Imaging · Emergency Diagnosis · Stroke
Website

Related Tools